Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey B Pilo‐de‐la‐Fuente, A Jimenez‐Escrig, JR Lorenzo, J Pardo, M Arias, ... European Journal of Neurology 18 (10), 1203-1211, 2011 | 144 | 2011 |
Influence of age and gender in motor performance in healthy subjects FJ Jiménez-Jiménez, M Calleja, H Alonso-Navarro, L Rubio, ... Journal of the Neurological Sciences 302 (1-2), 72-80, 2011 | 93 | 2011 |
Heme oxygenase-1 and 2 common genetic variants and risk for restless legs syndrome E García-Martín, FJ Jiménez-Jiménez, H Alonso-Navarro, C Martínez, ... Medicine 94 (34), e1448, 2015 | 37 | 2015 |
Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome FJ Jiménez-Jiménez, H Alonso-Navarro, C Martínez, M Zurdo, ... Journal of Neural Transmission 122, 819-823, 2015 | 27 | 2015 |
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population J Sabin, S Urtiaga, B Pilo, I Thuissard, V Galan, S Sainz de la Maza, ... Journal of Neurology 267, 2362-2371, 2020 | 26 | 2020 |
Association between vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the Spanish Caucasian population FJ Jiménez-Jiménez, E García-Martín, H Alonso-Navarro, C Martínez, ... Medicine 94 (47), e2125, 2015 | 26 | 2015 |
Treatment of severe bruxism with botulinum toxin type A H Alonso-Navarro, FJ Jimenez-Jimenez, JF Plaza-Nieto, ... Revista de neurologia 53 (2), 73-76, 2011 | 26 | 2011 |
The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome FJ Jiménez-Jiménez, H Alonso-Navarro, C Martínez, M Zurdo, ... Sleep medicine 15 (2), 266-268, 2014 | 22 | 2014 |
MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome A Roco, FJ Jiménez-Jiménez, H Alonso-Navarro, C Martínez, M Zurdo, ... Journal of Neural Transmission 120, 463-467, 2013 | 22 | 2013 |
Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis BP de la Fuente, MJ Sobrido, M Girós, L Pozo, M Lustres, F Barrero, ... Neurología (English Edition) 26 (7), 397-404, 2011 | 22 | 2011 |
Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome FJ Jiménez-Jiménez, H Alonso-Navarro, C Martínez, M Zurdo, ... Sleep medicine 14 (4), 382-384, 2013 | 21 | 2013 |
Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome FJ Jiménez-Jiménez, G Esguevillas, H Alonso-Navarro, M Zurdo, ... The Pharmacogenomics Journal 18 (4), 565-577, 2018 | 20 | 2018 |
Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome FJ Jiménez-Jiménez, E García-Martín, H Alonso-Navarro, C Martínez, ... Journal of Neural Transmission 124, 285-291, 2017 | 18 | 2017 |
Association Between the rs1229984 Polymorphism in the Alcohol Dehydrogenase 1B Gene and Risk for Restless Legs Syndrome FJ Jiménez-Jiménez, J Gómez-Tabales, H Alonso-Navarro, M Zurdo, ... Sleep 40 (12), zsx174, 2017 | 16 | 2017 |
Glioma therapy up-date BP de la Fuente, J Dalmau, M Rosenfeld Neurologia (Barcelona, Spain) 22 (3), 159-169, 2007 | 16 | 2007 |
Tratamiento del bruxismo grave con toxina botulínica tipo A H Alonso-Navarro, FJ Jiménez-Jiménez, JF Plaza-Nieto, ... Rev. Neurol 53, 73-76, 2011 | 11 | 2011 |
Disc configuration as a risk and prognostic factor in NAION: the impact of cup to disc ratio, disc diameter, and crowding index J González Martín-Moro, I Contreras, C Gutierrez-Ortiz, F Gómez-Sanz, ... Seminars in Ophthalmology 34 (3), 177-181, 2019 | 9 | 2019 |
Motor performance in patients with restless legs syndrome FJ Jiménez‐Jiménez, L Rubio, M Calleja, H Alonso‐Navarro, ... Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 7 | 2009 |
Acute monocular oligemia in a patient with migraine with aura demonstrated using OCT-angiography: A case report J González-Martín-Moro, J Porta Etessam, B Pilo de la Fuente, ... European Journal of Ophthalmology 33 (3), NP52-NP55, 2023 | 5 | 2023 |
Three-year effectiveness of dimethyl fumarate in multiple sclerosis: a prospective multicenter real-world study B Pilo De La Fuente, J Sabín, V Galán, I Thuissard, S Sainz de la Maza, ... CNS drugs 34, 1275-1286, 2020 | 5 | 2020 |